How PE Firms Can Maximize Their Buy-and-Build Strategies

Buy-and-build strategies, where PE firms acquire a platform company and then make synergistic investments in smaller companies, have grown in popularity in recent years.

More

You’ve heard about Robotic Process Automation: But what can it do for you?

Robotic process automation (RPA) has been a growing topic of conversation in organizations around the world.

More

5 Steps to Assess and Address the SEC’s Statement on SPAC Warrants

On April 12, 2021, the SEC issued a statement on the accounting for certain warrants issued by special purpose acquisition (SPAC) companies.

More

Why the Up-C Structure Is a Good Alternative Route to an IPO

The umbrella partnership C corporation (Up-C) structure has been a popular option for pass-through entities looking to gain access to the capital markets.

More

The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

Navigating SEC Comment Letters: Non-GAAP Disclosures and Metrics

Inevitably, companies looking to go public will face the prospect of comment letters from the Securities and Exchange Commission (SEC).

More

The Ultimate Guide to a Life Sciences IPO

The life sciences industry is in the middle of an IPO boom, with the 10 highest-valued biotech IPOs raising $3.

More

Get Ahead of Your Next Audit by Implementing ASC 606 Revenue Recognition Standards

Time is running out for any remaining companies to implement the latest ASC 606 revenue recognition standard.

More

How to Get Paid for Transformation (Shhh, Without Doing It All!)

The sell-side quality-of-earnings (QoE) report has become a critical piece of any private equity transaction.

More